Episode description
If there was ever a people who understand the importance of evidence-based healthcare, it’s the Germans, and they are starting to get very interested in psychedelic medicine. Today our guest is Dr. Andrea Jungaberle, co-founder of the MIND Foundation, a research center and nonprofit advocacy group for psychedelics in Berlin.
On the show we discuss the current landscape of psychedelic-assisted therapy in Germany. Andrea shares about the importance of evidence-based care and the forthcoming 144 person psilocybin study EPIsoDe on which the MIND Foundation is a collaborating partner. She details MINDS’ Augmented Psychotherapy Program and Insight Conference. Finally Andrea speaks about her book “Yoga, Tea, and LSD,” and her passion for using psychedelics to work with end-of-life anxiety.
Andrea is a co-founder and board member of the MIND Foundation. She also serves as OVID Health Systems’ Medical Director and MIND’s Director of Collaboration and Media. She is a clinical specialist in anesthesia and emergency medicine and currently training in cognitive behavioral psychotherapy. She is a certified Kundalini Yoga teacher, has participated in several accredited trainings in psychedelic therapy, and is part of the EPIsoDe study team, preparing to treat patients at Charité hospital in Germany’s first modern clinical trial involving psilocybin.
Links
Timestamps
- :04 - Andrea’s journey from inquisitive child to leading a psychedelic foundation
- :13 - The landscape in Germany for psychedelic-assisted therapy
- :17 - Evidence-based care and the EPIsoDe teams 144 person psilocybin study
- :26 - How psychedelic healthcare is beginning to be accepted in mainstream medicine in Germany
- :32 - The Mind Foundation’s Augmented Psychotherapy Program focuses on the science of classic psychedelics, breath work, and ketamine assisted therapy.
- :38 - The Insight Conference focusing on new ideas in psychedelics that conform to the scientific worldview
- :42 - Andrea’s book “Yoga, Tea, and LSD” and her interest in psychedelics and death